000 | 01645 a2200517 4500 | ||
---|---|---|---|
005 | 20250513202208.0 | ||
264 | 0 | _c20000309 | |
008 | 200003s 0 0 eng d | ||
022 | _a0959-8138 | ||
024 | 7 |
_a10.1136/bmj.320.7231.337 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aModell, B | |
245 | 0 | 0 |
_aInformed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential inquiry. _h[electronic resource] |
260 |
_bBMJ (Clinical research ed.) _cFeb 2000 |
||
300 |
_a337-41 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aChoice Behavior |
650 | 0 | 4 | _aEthnicity |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenetic Counseling |
650 | 0 | 4 | _aGenetic Services |
650 | 0 | 4 |
_aGenetic Testing _xmethods |
650 | 0 | 4 | _aHealth Policy |
650 | 0 | 4 | _aHeterozygote |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInformed Consent |
650 | 0 | 4 | _aMedical Audit |
650 | 0 | 4 | _aPatient Acceptance of Health Care |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aPregnancy Complications, Hematologic _xdiagnosis |
650 | 0 | 4 |
_aPrenatal Diagnosis _xmethods |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aStereotyping |
650 | 0 | 4 |
_aThalassemia _xgenetics |
650 | 0 | 4 | _aUnited Kingdom |
700 | 1 | _aHarris, R | |
700 | 1 | _aLane, B | |
700 | 1 | _aKhan, M | |
700 | 1 | _aDarlison, M | |
700 | 1 | _aPetrou, M | |
700 | 1 | _aOld, J | |
700 | 1 | _aLayton, M | |
700 | 1 | _aVarnavides, L | |
773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 320 _gno. 7231 _gp. 337-41 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.320.7231.337 _zAvailable from publisher's website |
999 |
_c10612295 _d10612295 |